IN THE PRESS
Press Releases
Read all Press Releases-
-
Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease
-
Alltrna Engineers tRNA Oligonucleotide with Improved Potency and Activity for In Vivo Readthrough of Premature Termination Codons
-
Alltrna Appoints Caroline Kӧhrer, Ph.D., Vice President, Discovery Platform
-
Alltrna Expands Leadership Team with Appointment of Joanne Protano as Chief Financial Officer
-
PharmaVoice 100 Stand-out Execs: Michelle Werner
-
In Vivo: Exploring Alltrna’s Rare Disease Platform
-
The Scientist: The Origins and Recent Promise of Nonsense Suppressor tRNAs
-
Boston Business Journal: Flagship-backed RNA startup company raises $109M
-
BioPharma Dive: Alltrna raises $109M for ‘transfer RNA’ drug vision